Antidepressants influence somatostatin levels and receptor pharmacology in brain

Neuropsychopharmacology

Volumn 34, Issue 4, 2009, Pages 952-963

  Pallis, Eleftherios ^a,c   Vasilaki, Anna ^a,b,d   Fehlmann, Dominique ^b   Kastellakis, Andreas ^a   Hoyer, Daniel ^b   Spyraki, Christina ^a   Thermos, Kyriaki ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d UNIVERSITY OF THESSALY   (Greece)

Author keywords

Autoradiography; Citalopram; Desmethylimipramine; Neuropeptide; Receptor binding; Somatostatin

Indexed keywords

CITALOPRAM; DESIPRAMINE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; RADIOIMMUNOASSAY; RAT; RECEPTOR DENSITY;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; AUTORADIOGRAPHY; BRAIN; CITALOPRAM; DESIPRAMINE; IMMUNOASSAY; IODINE RADIOISOTOPES; MALE; OCTREOTIDE; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN;

EID: 59949101573     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2008.133     Document Type: Article

References (55)

1. Artigas F, Adell A, Celada P (2006). Pindolol augmentation of antidepressant response. Current Drug Targets 7: 139-147.
2. Barnes NM, Sharp T (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38: 1083-1152.
3. Berton O, Nestler EJ (2006). New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7: 137-151.
4. Bissette G (2001). Effects on regional neuropeptide concentrations in olfactory bulbectomized rats. Pharmacol Biochem Behav 69: 269-281.
5. Bissette G, Klime V, Pan J, Stockmeier C, Ordway G (2003). Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology 28: 1328-1335.
6. Bissette G, Widerlov E, Walleus H, Karlsson I, Eklund K, Forsman A et al (1986). Alterations in cerebrospinal fluid concentrations of somatostatin like immunoreactivity in neuropsychiatric disorders. Arch Gen Psych 43: 1148-1151.
7. Bradford MM (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt Biochem 72: 248-254.
8. Brownstein MJ, Arimura A, Sato H, Schally AV, Kizer JS (1975). The regional distribution of somatostatin in the rat brain. Endocrinology 96: 1456-1461.
9. Carboni E, Spielewoy C, Vacca C, Nosten-Bertrand M, Giros B, Di Chiara G (2001). Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J Neurosci 21: RC141(1-4).
10. Charlton B, Leake A, Wright C, Fairbairan AF, McKeith IG, Candy JM et al (1988). Somatostatin content and receptors in cerebral cortex of depressed and control subjects. J Neurol Neurosurg Psychiatry 51: 719-721.
11. Charney DS, Menkes DB, Heninger GR (1981). Receptor sensitivity and the mechanisms of action of antidepressant treatment: implications for the etiology and therapy of depression. Arch Gen Psychiatry 38: 1160-1180.
12. Chihara K, Arimura A, Schally AV (1979). Effects of intraventricular injection of dopamine, norepinephrine, acetylcholine, and 5-hydroxytryptamine on immunoreactive somatostatin release into rat hypophyseal portal blood. Endocrinology 104: 1656-1661.
13. Daws C, Toney GM, Gerhardt GA, Frazer A (1998). In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters. J Pharmacol Exp Ther 286: 967-976.
14. Dournaud P, Boudin H, Schonbrunn A, Tannenbaum GS, Beaudet A (1998). Interrelationships between somatostatin sst2A receptors and somatostatin- containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin. J Neurosci 18: 1056-1071.
15. 8]somatostatin-14 binding sites in the locus coeruleus of the rat are located on both ascending and descending projecting noradrenergic cells. Peptides 11: 21-27.
16. Fehlmann D, Langenegger D, Schuepbach E, Siehler S, Feuerbach D, Hoyer D (2000). Distribution and characterization of somatostatin receptor mRNA and binding sites in the brain and periphery. J Physiol Paris 94: 265-281.
17. Gerner RH, Yamada T (1982). Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients. Brain Res 238: 298-302.
18. Gheorvassaki EG, Thermos K, Liapakis G, Spyraki C (1992). Effects of acute and chronic desipramine treatment on somatostatin receptors in brain. Psychopharmacology 108: 363-366.
19. Hathway GJ, Humphrey PP, Kendrick KM (1999). Evidence that somatostatin sst2 receptors mediate striatal dopamine release. Br J Pharmacol 128: 1346-1352.
20. Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humprey PP et al (1995). Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 16: 86-88.
21. Kakigi T, Maeda K (1992). Effect of serotonergic agents on regional concentration of somatostatin and neuropeptide Y-like immunoreactivities in rat brain. Brain Res 599: 42-50.
22. Kakigi T, Maeda K, Kaneda H, Chihara K (1992). Repeated administration of antidepressant drugs reduces regional somatostatin concentration in rat brain. J Affect Dis 25: 215-220.
23. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ et al (1998). Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281: 1640-1645.
24. Kreienkamp H-J, Roth A, Richter D (1998). Rat somatostatin receptor subtype 4 can be made sensitive to agonist-induced internalization by mutation of a single threonine (residue 331). DNA Coll Biol 17: 869-878.
25. Lopez-Sanudo S, Arilla E (1992). Desmethylimipramine pretreatment prevents 6-hydroxydopamine induced somatostatin receptor reduction in the rat hippocampus. Regul Pept 41: 227-236.
26. Luttgen M, OveOgren S, Meister B (2004). Chemical identity of 5-HT2A receptor immunoreactive neurons of the rat septal complex and dorsal hippocampus. Brain Res 1010: 156-165.
27. Mikkelsen JD, Woldbye DPD (2006). Accumulated increase in neuropeptide Y and somatostatin gene expression of the rat in response to repeated electroconvulsive stimulation. J Psych Res 40: 153-159.
28. Munoz-Acedo G, Lopez-Sanudo S, Arilla E (1992). Reduction of somatostatin receptors in rat hippocampus by treatment with 5,7-dihydroxytryptamine. Neurosci Lett 146: 60-64.
29. Nouel D, Gaudriault G, Goule M, Reisine T, Vincent J-P, Mazella J et al (1997). Differential internalization of somatostatin in COS-7 cells transfected with sst1 and sst2 receptor subtype: a confocal microscopic study using novel fluorescent somatostatin derivatives. Endocrinology 138: 296-306.
30. Palkovits M, Brownstein MJ (1988). Maps and Guides to Microdissection of the Rat Brain. Elsevier: New York.
31. Pallis E, Spyraki C, Thermos K (2006). Chronic antidepressant treatment modulates the release of somatostatin in the rat nucleus accumbens. Neurosci Lett 395: 76-81.
32. Pallis E, Thermos K, Spyraki C (2001). Chronic desipramine treatment selectively potentiates somatostatin-induced dopamine release in the nucleus accumbens. Eur J Neurosci 14: 763-767.
33. Palvimaki EP, Majasuo H, Syvalahti E, Hietala J (2005). Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroidplexus after fluoxetine and citalopram treatments. Pharmacol Res 51: 419-425.
34. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates, 4th edn, Academic Press Inc: San Diego.
35. Pazzaglia PJ, George MS, Post RM, Rubinow DR, Davis CL (1995). Nimodipine increases somatostatin in affective ill patients. Neuropsychopharmacology 13: 75-83.
36. Prosperini E, Rizzi M, Fumagalli F, Tarizzo G, Samanin R, Bendotti C (1997). Acute and chronic treatments with citalopram lower somatostatin levels in rat brain striatum through different mechanisms. J Neurochem 69: 206-213.
37. Raynor K, Lucki I, Reisine T (1993). Somatostatin-1 receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity. J Pharmacol Exp Ther 265: 67-73.
38. Richardson SB, Hollander CS, Prasad JA, Hirooka Y (1981). Somatostatin release from rat hypothalamus in vitro: effects of melatonin and serotonin. Endocrinology 109: 602-606.
39. Roosterman D, Kreuzer OJ, Brune N, Cottrell GS, Bunnett NW, Meyerhof W et al (2007). Agonist-induced endocytosis of rat somatostatin receptor 1. Endocrinology 148: 1050-1058.
40. Rubinow DR (1986). Cerebrospinal fluid somatostatin and psychiatric illness. Biol Psychiatry 21: 341-365.
41. Rubinow DR, Gold PW, Post R, Ballenger JC, Cowdry R, Bollinger J et al (1983). CSF somatostatin in affective illness. Arch Gen Psych 40: 409-412.
42. Schindler M, Kidd EJ, Carruthers AM, Jarvie EM, Sellers LA, Feniuk W et al (1998). Molecular cloning and functional characterization of a rat somatostatin sst2(B) receptor splice variant. Br J Pharmacol 25: 209-217.
43. Schulz S, Handel M, Schreff M, Schmidt H, Hollt V (2000). Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies. J Phys Paris 94: 259-264.
44. Siehler S, Seuwen K, Hoyer D (1999). Characterisation of human recombinant somatostatin receptors: 1 radioligand binding studies. Nauyn Schmied Arch Pharmacol 360: 488-499.
45. Skolnick P, Legutko B, Li X, Bymaster FP (2001). Current perspectives on the development of non-biogenic amine-based antidepressants. Pharmacol Res 43: 411-443.
46. Stahl SM (1998). Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Dis 51: 215-235.
47. Stroh T, Jackson AC, Dal Farra C, Schonbrunn A, Vincent JP, Beaudet A (2000). Receptor-mediated internalization of somatostatin in rat cortical and hippocampal neurons. Synapse 38: 177-186.
48. Thermos K, Bagnoli P, Epelbaum J, Hoyer D (2006). The somatostatin sst1 receptor: an autoreceptor for somatostatin in brain and retina? Pharmacol Ther 110: 455-464.
49. Thermos K, Radke J, Kastellakis A, Anagnostakis Y, Spyraki C (1996). Dopamine-somatostatin interactions in the rat striatum: an in vivo microdialysis study. Synapse 22: 209-216.
50. Thoss VS, Perez J, Duc D, Hoyer D (1995). Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain. Neuropharmacology 34: 1673-1688.
51. Vasilaki A, Papasava D, Hoyer D, Thermos K (2004). The somatostatin receptor (sst1) modulates the release of somatostatin in the nucleus accumbens of the rat. Neuropharmacology 47: 612-618.
52. 8-somatostatin binding in sst1- to sst4- and SRIF-gene-invalidated mouse brain. Nauyn Schmied Arch Pharmacol 367: 562-571.
53. Vincent SR, Johansson O (1983). Striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities and NADPH-diaphorase activity: a light and electron microscopic study. J Comp Neurol 217: 264-270.
54. Wong M, Licinio J (2004). From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat Rev Drug Discov 3: 136-151.
55. Zobel AW, Nicke T, Kunze HE, Ackl N, Sonntag A, Ising M et al (2000). Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiat Res 34: 171-181.